Mechanisms and etiologies of thrombocytopenia in the intensive care unit: impact of extensive investigations

Annals of Intensive Care

Volumn 4, Issue 1, 2014, Pages 1-7

  Antier, Nadiejda ^a   Quenot, Jean Pierre ^b   Doise, Jean Marc ^a   Noel, Robin ^a   Demaistre, Emmanuel ^b   Devilliers, Hervé ^c  

^a Centre Hospitalier Chalon sur Saone   (France)

^b HÔPITAL DU BOCAGE   (France)

^c DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Bone marrow aspiration; Intensive care unit; Thrombocytopenia

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BLOOD CLOTTING FACTOR 5; CYANOCOBALAMIN; D DIMER; FERRITIN; FIBRIN MONOMER; FIBRINOGEN; FOLIC ACID; HAPTOGLOBIN; LACTATE DEHYDROGENASE; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BONE MARROW BIOPSY; CLINICAL ARTICLE; DILUTION; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROPHAGOCYTOSIS; FEMALE; FERRITIN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; HEMOFILTRATION; HUMAN; HYPERSPLENISM; INTENSIVE CARE UNIT; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTHROMBIN TIME; RETICULOCYTE; THROMBOCYTOPENIA; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

EID: 84947028937     PISSN: None     EISSN: 21105820     Source Type: Journal    
DOI: 10.1186/s13613-014-0024-x     Document Type: Article

References (36)

1. Priziola JL, Smythe MA, Dager WE: Drug-induced thrombocytopenia in critically ill patients.Crit Care Med 2010, 38:S145–S154.
2. Strauss R, Wehler M, Mehler K, Mehler K, Kreutzer D, Koebnick C, Hahn EG: Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome.Crit Care Med 2002, 30:1765–1771.
3. Akca S, Haji-Michael P, de Mendonca A, Suter P, Levi M, Vincent JL: Time course of platelet counts in critically ill patients.Crit Care Med 2002, 30:753–756.
4. Moreau D, Timsit JF, Vesin A, Garrouste-Orgeas M, de Lassence A, Zahar J-R, Adrie C, Vincent F, Cohen Y, Schlemmer B, Azoulay E: Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays.Chest 2007, 131:1735–1741.
5. Stephan F, Montblanc J, Cheffi A, Bonnet F: Thrombocytopenia in critically ill surgical patients: a case-control study evaluating attributable mortality and transfusion requirements.Crit Care 1999, 3:151–158.
6. Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, Bobbaers H: Thrombocytopenia and prognosis in intensive care.Crit Care Med 2000, 28:1871–1876.
7. Rice TW, Wheeler AP: Coagulopathy in critically ill patients: part 1: platelet disorders.Chest 2009, 136:1622–1630.
8. Lim SY, Jeon EJ, Kim HJ, Jeon K, Um SW, Koh WJ, Chung MP, Kim H, Kwon OJ, Suh GY: The incidence, causes, and prognostic significance of new-onset thrombocytopenia in intensive care units: a prospective cohort study in a Korean hospital.J Korean Med Sci 2012, 27:1418–1423.
9. Stephan F, Hollande J, Richard O, Cheffi A, Maier-Redelsperger M, Flahault A: Thrombocytopenia in a surgical ICU.Chest 1999, 115:1363–1370.
10. Van der Linden T, Souweine B, Dupic L, Soufir L, Meyer P: Management of thrombocytopenia in the ICU (pregnancy excluded).Ann Intensive Care 2012, 2:42.
11. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A: Evaluation of pretest clinical score (4 T’s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings.J Thromb Haemost 2006, 4:759–765.
12. Warkentin TE: Heparin-induced thrombocytopenia: diagnosis and management.Circulation 2004, 110:e454–e458.
13. Warkentin TE, Heddle NM: Laboratory diagnosis of immune heparin-induced thrombocytopenia.Curr Hematol Rep 2003, 2:148–157.
14. Thiolliere F, Serre-Sapin AF, Reignier J, Benedit M, Constantin JM, Lebert C, Guélon D, Timsit JF, Souweine B: Epidemiology and outcome of thrombocytopenic patients in the intensive care unit: results of a prospective multicenter study.Intensive Care Med 2013, 39:1460–1468.
15. Wada H, Thachil J, Di Nisio M, Mathew P, Kurosawa S, Gando S, Kim HK, Nielsen JD, Dempfle CE, Levi M, Toh CH: Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines.J Thromb Haemost 2013, 11:761–767.
16. Stephan F, Thiolliere B, Verdy E, Tulliez M: Role of hemophagocytic histiocytosis in the etiology of thrombocytopenia in patients with sepsis syndrome or septic shock.Clin Infect Dis 1997, 25:1159–1164.
17. Buyse S, Teixeira L, Galicier L, Mariotte E, Lemiale V, Seguin A, Bertheau P, Canet E, de Labarthe A, Darmon M, Rybojad M, Schlemmer B, Azoulay E: Critical care management of patients with hemophagocytic lymphohistiocytosis.Intensive Care Med 2010, 36:1695–1702.
18. Creput C, Galicier L, Buyse S, Azoulay E: Understanding organ dysfunction in hemophagocytic lymphohistiocytosis.Intensive Care Med 2008, 34:1177–1187.
19. Creput C, Galicier L, Oksenhendler E, Azoulay E: Pathophysiology of organ dysfunction in the macrophage activation syndrome.Reanimation 2005, 4:604–613.
20. Gonzalez F, Vincent F, Cohen Y: Macrophage activation syndrome of infectious origin: etiology and management.Reanimation 2009, 18:284–290.
21. Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL: How I treat hemophagocytic lymphohistiocytosis.Blood 2011, 118:4041–4052.
22. Larroche C: Hemophagocytic lymphohistiocytosis in adults: diagnosis and treatment.Joint Bone Spine 2012, 79:356–361.
23. Strauss R, Neureiter D, Westenburger B, Wehler M, Kirchner T, Hahn EG: Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients–a postmortem clinicopathologic analysis.Crit Care Med 2004, 32:1316–1321.
24. Bain BJ: Bone marrow biopsy morbidity and mortality: 2002 data.Clin Lab Haematol 2004, 26:315–318.
25. Bain BJ: Bone marrow biopsy morbidity: review of 2003.J Clin Pathol 2005, 58:406–408.
26. Bain BJ: Morbidity associated with bone marrow aspiration and trephine biopsy - a review of UK data for 2004.Haematologica 2006, 91:1293–1294.
27. Martino M, Console G, Russo L, Messina G, D'Arro' BL, Irrera G, Barreca G: Internal iliac artery perforation following bone marrow aspiration in a patient with no previously identified risk factors: a case report and review of the literature.Acta Haematol 2012, 127:23–25.
28. Tsai HL, Liu SW, How CK, Chern CH, Yen DHT, Huang CI: A rare case of massive retroperitoneal hemorrhage after bone marrow aspiration alone.Am J Emerg Med 2008, 26(1070):e5–e6.
29. Baughman RP, Lower EE, Flessa HC, Tollerud DJ: Thrombocytopenia in the intensive care unit.Chest 1993, 104:1243–1247.
30. Bat T, Leitman SF, Calvo KR, Chauvet D, Dunbar CE: Measurement of the absolute immature platelet number reflects marrow production and is not impacted by platelet transfusion.Transfusion 2013, 53(6):1201–1204.
31. Briggs C, Kunka S, Hart D, Oguni S, Machin SJ: Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia.Br J Haematol 2004, 126:93–99.
32. Briggs C, Longair I, Kumar P, Singh D, Machin SJ: Performance evaluation of the Sysmex haematology XN modular system.J Clin Pathol 2012, 65:1024–1030.
33. Ingram M, Coopersmith A: Reticulated platelets following acute blood loss.Br J Haematol 1969, 17:225–229.
34. Pons I, Monteagudo M, Lucchetti G, Muñoz L, Perea G, Colomina I, Guiu J, Obiols J: Correlation between immature platelet fraction and reticulated platelets. Usefulness in the etiology diagnosis of thrombocytopenia.Eur J Haematol 2010, 85:158–163.
35. Ruisi MM, Psaila B, Ward MJ, Villarica G, Bussel JB: Stability of measurement of the immature platelet fraction.Am J Hematol 2010, 85:622–624.
36. Selleng K, Warkentin TE, Greinacher A: Heparin-induced thrombocytopenia in intensive care patients.Crit Care Med 2007, 35:1165–1176.